| |
| |
Credits | |
| |
| |
Acknowledgments | |
| |
| |
Introduction | |
| |
| |
Better Clinical Research Is Needed | |
| |
| |
References | |
| |
| |
| |
Cardiopulmonary Agents | |
| |
| |
| |
Beta-Receptor Antagonists (Beta-Blockers) | |
| |
| |
How Exercise Affects the Action of Beta-Blockers | |
| |
| |
How Beta-Blockers Affect Exercisers | |
| |
| |
How Beta-Blockers Affect Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Diuretics | |
| |
| |
How Exercise Affects the Action of Diuretics | |
| |
| |
How Diuretics Affect Exercisers | |
| |
| |
How Diuretics Affect Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Other Antihypertensive Drugs | |
| |
| |
How Exercise Affects the Action of Antihypertensive Drugs | |
| |
| |
How Antihypertensive Drugs Affect Exercisers | |
| |
| |
How Antihypertensive Drugs Affect Exercise Performance | |
| |
| |
Can a Conditioning Effect Be Achieved While Taking Antihypertensive Drugs? | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Sympathomimetics | |
| |
| |
How Exercise Affects the Action of Sympathomimetics | |
| |
| |
How Sympathomimetics Affect Exercisers | |
| |
| |
How Sympathomimetics Affect Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Bronchodilators and Respiratory Anti-Inflammatory Agents | |
| |
| |
Exercise-Induced Bronchoconstriction | |
| |
| |
Introduction to Respiratory Drugs | |
| |
| |
How Exercise Affects the Action of Bronchodilators and Respiratory Anti-Inflammatory Agents | |
| |
| |
How Respiratory Agents Affect Exercisers | |
| |
| |
How Respiratory Agents Affect Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Hormonal Agents | |
| |
| |
| |
Human Growth Hormone | |
| |
| |
Somatrem and Somatropin | |
| |
| |
How Exercise Affects the Action of Growth Hormone | |
| |
| |
How Growth Hormone Affects Exercisers | |
| |
| |
How Growth Hormone Affects Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Androgenic-Anabolic Steroids | |
| |
| |
How Exercise Affects the Action of Androgenic-Anabolic Steroids | |
| |
| |
How Androgenic-Anabolic Steroids Affect Exercisers | |
| |
| |
How Androgenic-Anabolic Steroids Affect Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Metabolic Agents | |
| |
| |
| |
Creatine | |
| |
| |
How Exercise Affects the Action of Creatine Supplements | |
| |
| |
Dosing Strategies and Effects on Tissue Concentrations of Creatine | |
| |
| |
How Creatine Supplements Affect Exercisers | |
| |
| |
How Creatine Supplements Affect Exercise Performance | |
| |
| |
Dietary Factors and Their Effects on the Response to Creatine | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Iron and Erythropoietin (Epoetin Alfa) | |
| |
| |
Hematinic Agents | |
| |
| |
How Exercise Affects the Action of Epoetin Alfa and Iron | |
| |
| |
How Epoetin Alfa and Iron Supplements Affect Exercisers | |
| |
| |
How Epoetin Alfa and Iron Supplements Affect Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Antilipemic Agents | |
| |
| |
Antilipemic Agents | |
| |
| |
How Exercise Affects the Action of Antilipemic Agents | |
| |
| |
How Antilipemic Agents Affect Exercisers | |
| |
| |
How Antilipemic Agents Affect Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Salicylates | |
| |
| |
Anti-Inflammatory Agents | |
| |
| |
How Exercise Affects the Action of Anti-Inflammatory Agents | |
| |
| |
How Anti-Inflammatory Agents Affect Exercisers | |
| |
| |
How Anti-Inflammatory Agents Affect Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Nutritional Supplements | |
| |
| |
Pharmaceutical or Nutraceutical? The DSHEA Law of 1994 | |
| |
| |
DHEA and Androstenedione | |
| |
| |
Chromium | |
| |
| |
Coenzyme Q-10 | |
| |
| |
Sodium Bicarbonate | |
| |
| |
References | |
| |
| |
| |
Socially Used Drugs | |
| |
| |
| |
Caffeine | |
| |
| |
How Exercise Affects the Action of Caffeine | |
| |
| |
How Caffeine Affects Exercisers | |
| |
| |
How Caffeine Affects Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Ethanol | |
| |
| |
How Exercise Affects the Action of Ethanol | |
| |
| |
How Ethanol Affects Exercisers | |
| |
| |
How Ethanol Affects Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Amphetamines and Cocaine | |
| |
| |
How Exercise Affects the Action of Cocaine and Amphetamines | |
| |
| |
How Cocaine and Amphetamines Affect Exercisers | |
| |
| |
How Amphetamines and Cocaine Affect Exercise Performance | |
| |
| |
Avoiding Potential Complications | |
| |
| |
References | |
| |
| |
| |
Final Thoughts | |
| |
| |
| |
Exercise: The Overlooked Prescription | |
| |
| |
Improving the Therapeutic Use of Exercise | |
| |
| |
Becoming More Proactive in Recommending Exercise | |
| |
| |
Guidelines for Physicians, Trainers, Teachers, and Parents | |
| |
| |
References | |
| |
| |
Additional Information Sources for Drugs and Exercise | |
| |
| |
About the Author | |